Overview

Improvement of Pain Following Robotic Sacrocolpopexy and Rectocele Repair for Pelvic Organ Prolapse

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
To determine if the injection of liposomal bupivacaine to laparoscopic port sites and rectocele repair incisions at the completion of a robotic sacrocolpopexy with concomitant rectocele repair will result in decreased postoperative pain compared to injection of placebo.
Phase:
Phase 4
Details
Lead Sponsor:
TriHealth Inc.
Treatments:
Bupivacaine